The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing quality of care in early stage resected stage non-small cell lung cancer (NSCLC): An evaluation of epidermal growth factor receptor (EGFR) testing and adjuvant (adj) therapy (tx).
 
Brian Patrick Mulherin
Honoraria - Alexion Pharmaceuticals; Caris Life Sciences; CTI BioPharma Corp; Daiichi Sankyo/Lilly; Incyte; Janssen Oncology; Janssen Oncology; Kite/Gilead; Swedish Orphan Biovitrum; TG Therapeutics
Consulting or Advisory Role - Apellis Pharmaceuticals; Novartis; Vertex
Speakers' Bureau - Apellis Pharmaceuticals
Research Funding - Apellis Pharmaceuticals; Novartis (Inst); Pharmacyclics/Janssen
Travel, Accommodations, Expenses - Apellis Pharmaceuticals; Incyte; Kite, a Gilead company
 
Jia Zeng
No Relationships to Disclose
 
Anupama Vasudevan
Employment - IntegraConnect; IntegraConnect
Stock and Other Ownership Interests - McKesson
 
Erin Alwon
No Relationships to Disclose
 
Mike Gart
Employment - IntegraConnect
Stock and Other Ownership Interests - Abbott; Becton Dickinson; Boston Scientific (I); Cerner (I); Charles River Laboratories; Elanco; Gilead Sciences (I); The Cigna Group; Thermo Fisher Scientific (I)
 
Simon Blanc
Employment - IntegraConnect
Stock and Other Ownership Interests - CTI BioPharma Corp
Consulting or Advisory Role - Pfizer
 
Stephen G. Divers
Stock and Other Ownership Interests - American Oncology Network
Consulting or Advisory Role - Caris Life Sciences; Cellectar; Daiichi Sankyo/Lilly; Mirati Therapeutics